Evidence map›Paper›PMID 23323793›Full record

ArticleClinical genetics2013

Variants of uncertain significance in BRCA testing: evaluation of surgical decisions, risk perception, and cancer distress.

J O Culver, C D Brinkerhoff, J Clague, K Yang, K E Singh, S R Sand, J N Weitzel

Abstract read
In one paragraph

Article in Clinical genetics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. How variants of uncertain significance affect clinical decisions: A systematic review.Genetics in medicine : official journal of the American College of Medical Genetics · 2026
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Assessing the Clinical Relevance ofCurrent oncology (Toronto, Ont.) · 2026
    Article
  5. Article
  6. Article
  7. Reclassification ofEuropean journal of breast health · 2025
    Article
  8. Article
  9. Article
  10. The landscape of reported VUS in multi-gene panel and genomic testing: Time for a change.Genetics in medicine : official journal of the American College of Medical Genetics · 2023
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Racial and Ethnic Disparities in Germline Genetic Testing of Patients With Young-Onset Colorectal Cancer.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

J O CulverDivision of Clinical Cancer Genetics, City of Hope, Duarte, CA, USA.
C D Brinkerhoff
J Clague
K Yang
K E Singh
S R Sand
J N Weitzel

Funding

CLINICAL CANCER GENETICS FELLOWSHIP PROGRAMR25CA085771 · NCI · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI WEITZEL, JEFFREY N · 2001 to 2010
$3.8M
Clinical Cancer Genetics Community Network: A Sustainable Research PartnershipRC4CA153828 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI WEITZEL, JEFFREY N · 2010 to 2010
$1.0M
NCI NIH HHS R25 CA085771NCI NIH HHS R25CA085771NCI NIH HHS RC4 CA153828NCI NIH HHS RC4CA153828
6 · The paper itself

Abstract

Studies suggest that patients carrying a BRCA variant of uncertain significance (VUS) may have lingering confusion concerning results interpretation. Counseling for uninformative BRCA-negative (UN) results is thought to be more straightforward, despite the fact that both results lead to similar methods of empiric cancer risk counseling. This study compared surgical choices and perceptions between 71 patients with VUS results and 714 patients with UN results. All patients underwent genetic counseling because of a personal or family history of breast or ovarian cancer between 1997 and 2010, and completed a 2-year follow-up survey. Risk-reducing mastectomy rates in both groups were 7% (p = 1.00) and risk-reducing oophorectomy rates were 5% and 3%, respectively (p = 0.42). The VUS group reported less cancer distress reduction than the UN group (23.0% vs 35.8%, respectively, p = 0.043). Over 90% of both groups found the counseling process helpful. Overall, the study suggests that VUS results disclosed in genetic counseling did not cause excessive surgery or exaggerated cancer distress, though patients with a VUS found counseling somewhat less informative or reassuring. Future research on communication of VUS results, including pre-and post-test counseling, is essential for full realization of the potential for genomic medicine.

Indexed as

Genetic VariationStress, PsychologicalAdultBRCA1 ProteinBRCA2 ProteinBreast NeoplasmsFemaleFollow-Up StudiesGenetic CounselingGenetic Predisposition to DiseaseHumansMastectomyMiddle AgedOvarian NeoplasmsOvariectomyRisk AssessmentBRCA1 ProteinBRCA1 protein, humanBRCA2 ProteinBRCA2 protein, humanBRCA1 geneBRCA2 genegenetic counselinghereditary breast and ovarian cancer syndromemutation missensevariant of uncertain significance

Identifiers

PMID23323793
PMCPMC3751990

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.